Martin Olivier

Martin Olivier is a Senior Scientist at the Research Institute of the McGill University Health Centre (RI-MUHC), Glen site, and a Professor in the Department of Medicine at McGill University's Faculty of Medicine and Health Sciences. He specializes in Infectious Diseases and Immunity in Global Health, focusing on protozoan pathogens like Leishmania and Plasmodium (malaria). His work explores how these parasites manipulate host immune responses through biochemical pathways and extracellular vesicles.

• Institutional Affiliations: RI-MUHC (Senior Scientist); McGill University (Professor)
• Program: Infectious Diseases and Immunity in Global Health
• Centre: Centre for Translational Biology

Research Highlights: Olivier's lab has uncovered critical mechanisms such as Leishmania's use of surface proteases to suppress innate inflammation, the role of malaria's hemozoin in inflammation-related pathologies, and the regulatory impact of circadian rhythms on parasite-host interactions. These findings may lead to novel therapies, diagnostics based on exo-biomarkers, and vaccine strategies.

Publication Trends (2023-2025): His recent work emphasizes extracellular vesicle dynamics in parasitic infections, circadian regulation of pathogenesis, and genomic diversity in vector-borne pathogens. Collaborative efforts include standardizing EV research methodologies (MISEV2023) and exploring antiparasitic drug development.

Labs & Collaborations: Leads research at RI-MUHC's Glen site, affiliated with McGill's Department of Medicine. His team investigates host-pathogen communication, iron metabolism in malaria, and EV-mediated immune modulation across multiple infections.